Across TCGA pan-cancer cohorts, MTCO1P39 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated MTCO1P39 data layer.
The strongest signal is observed in lung adenocarcinoma (LUAD), where higher MTCO1P39 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MTCO1P39 expression acts as an unfavorable survival marker, although some lineages such as CHOL and BLCA show a favorable association.
LUAD, MESO, and KIRC are the cancer types where MTCO1P39 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.